Lyza
Product Images NDC 50102-100

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lyza (NDC 50102-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Afaxys Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (47c0066b 30d1 4b02 B4da 5ea90fb9ea8a 01)

Chemical structure of Norethindrone, the active ingredient shown in a steroidal form with hydroxyl, methyl, and ethynyl functional groups.*

FDA Label Image

Afaxys Logo (47c0066b 30d1 4b02 B4da 5ea90fb9ea8a 02)

FDA Label Image

Recyclable Paper (47c0066b 30d1 4b02 B4da 5ea90fb9ea8a 03)

FDA Label Image

Monocarton (47c0066b 30d1 4b02 B4da 5ea90fb9ea8a 04)

Packaging label for Lyza Norethindrone Tablets USP 0.35 mg by Afaxys Pharma LLC. The label shows the product name and strength prominently, with dosage form as tablets. It includes manufacturer and distributor details, barcode, and directions for use on a white background with purple accents. The package contains 3 blister packs of 28 tablets each.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.